Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban versus lepirudin in critically ill patients with suspected or confirmed HIT undergoing renal replacement therapy
2006-003122-28Phase 4Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Aug 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of argatroban and lepirudin in heparin-induced thrombocytopenia (HIT) (2 arms), sponsored by Heinrich Heine University Düsseldorf. Primary endpoint: Mean runtime of two consecutive haemodialysis circuits. Started Aug 2008; status: completed.
02
Drugs
argatrobanlepirudin
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on 2006-003122-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003122-28.